What is DPP-4 and why is it relevant to GLP-1 research?
glp1dpp-4science
DPP-4 (dipeptidyl peptidase-4) is an enzyme that can inactivate certain incretin hormones, including native GLP-1.
In GLP-1 research, many GLP-1 analogs are modified to resist enzymatic breakdown (including by DPP-4), which can affect stability and duration of signaling.
For research use only. Not medical advice.
Related questions
- What is peptide receptor selectivity (and why does it matter in research)?
- What is peptide bioavailability (and why is it often low)?
- Why are most peptides not orally active?
- What is enzymatic degradation in peptides?
- What is albumin binding and how can it extend peptide half-life?
- What are peptide fragments vs full-length peptides?
Browse all FAQs about research peptides, sourcing, and Peptide Library.
View all FAQs